News

USHK News
2022.07.11 02:08
腾盛博药 (02137.HK) 涨超 30%，新冠中和抗体药物在中国商业化上市，对 BA.5 变异株保持有效性，定价不超 1 万元。
Source: USHK News The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.